Lightnews — Scholar-powered news

Reposted by Jim Catto

BURSTurology @bursturology.bsky.social · May 28

🚀 Exciting announcement!

⭐️ Join us at #BAUS25 for our special session on Monday, 16 June!

🕓 16:30 - 16:45
📍 Charter 3

📢 We are thrilled to welcome our keynote speaker, Freddie Hamdy, who will discuss, "The Challenge of Misinformation"!

#BURSTatBAUS #UroSoMe @bausurology.bsky.social

2 1

Reposted by Jim Catto

Sophia Anderton @sophiaanderton.bsky.social · Jun 16

An important (very short) film from Steve McQueen - don’t be embarrassed to talk about #ProstateCancer. Can effect all men but there’s a higher risk for black men.

www.embarrassedfilm.org

It’ll take less than 2 mins of your time to watch.
An inspiring talk at #BAUS25

www.embarrassedfilm.org | A SIR STEVE MCQUEEN FILM Raising awareness of prostate cancer within the black community

www.embarrassedfilm.org

1

Reposted by Jim Catto

Hashim Ahmed @londonprostate1.bsky.social · Mar 5

Inaccuracy of rapid at home PSA tests

www.bbc.co.uk/news/article...

Prostate cancer: Rapid at-home PSA tests spark concerns

Testing for PSA protein can indicate whether a man is at risk of prostate cancer.

www.bbc.co.uk

1 2

Reposted by Jim Catto

Dr Rachel Hubbard @drrachelhubbard.bsky.social · Feb 11

Woohoo! Great work team

@jimcatto.bsky.social

bmjopen.bmj.com/content/bmjo...

bmjopen.bmj.com

1 1

Jim Catto @jimcatto.bsky.social · Feb 4

www.sheffield.ac.uk/news/thousan...

Thousands of men in Yorkshire to take part in new prostate screening trial

Thousands of men in Yorkshire will be offered the opportunity to take part in a new £4.5 million prostate screening trial led by the University of Sheffield.

www.sheffield.ac.uk

2 2 10

Jim Catto @jimcatto.bsky.social · Feb 4

www.yorkshirecancerresearch.org.uk/news/thousan...

Thousands of men in Yorkshire to take part in new prostate screening trial - Yorkshire Cancer Research

Thousands of men in Yorkshire will be offered the opportunity to take part in a new £4.5 million prostate screening trial funded by Yorkshire Cancer Research.

www.yorkshirecancerresearch.org.uk

1 2

Jim Catto @jimcatto.bsky.social · Jan 16

Yes.

Reposted by Jim Catto

Imperial Prostate @ip-london.bsky.social · Jan 15

🏃 Flying start to #IP9ATLAS - first 5️⃣0️⃣ patients recruited!

🔎 Comparing regular MRI scans to standard of care in patients with prostate cancer on active surveillance

🎉 Thank you to our site teams Imperial College Healthcare NHST, Dartford and Gravesham NHST & Frimley Health NHSFT

4 4

Reposted by Jim Catto

Yüksel Ürün @yukselurun.bsky.social · Jan 15

Can mpMRI replace TURBT for faster treatment in MIBC?
A randomized study shows that the mpMRI-first approach reduced the time to treatment by 45 days (53 vs. 98 days). No harm to non-MIBC patients. A game-changer for staging? #Oncology @oncoalert.bsky.social
ascopubs.org/doi/10.1200/JC…

1 3 8

Jim Catto @jimcatto.bsky.social · Jan 15

Great to see this finally out #bladdercancer

ascopubs.org/doi/10.1200/...

Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial

PURPOSETransurethral resection of bladder tumor (TURBT) is the initial staging procedure for new bladder cancers (BCs). For muscle-invasive bladder cancers (MIBCs), TURBT may delay definitive treatmen...

ascopubs.org

2 7

Reposted by Jim Catto

Sabine D. Brookman-May, MD, FEBU🚴‍♀️🚴‍♀️🚴‍♀️🏔️⛷️⛰️ @brookmans76.bsky.social · Jan 15

Now published: This MA is the basis for our ongoing #ZMoveMent1 study evaluating the impact of endurance*resistance training on QoL, oncological outcomes, fitness in #ProstateCancee pts
👉 we still don’t use #PhysicalExercise in cancer pts in an optimal way
👉 www.mdpi.com/2072-6694/16...

1

Jim Catto @jimcatto.bsky.social · Jan 13

www.sheffield.ac.uk/news/surviva...

Survival rates for patients with operable bladder cancer significantly improved by immunotherapy before and after surgery

A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to b...

www.sheffield.ac.uk

2 6

Reposted by Jim Catto

OncoDaily @oncodaily.bsky.social · Jan 12

Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer

oncodaily.com/insight/sasa...

#BladderCancer #Cancer #EventFreeSurvival #EFS #OncoDaily #Oncology #Pfizer #Sasanlimab

Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer - OncoDaily

Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer / bladder cancer, cancer, event-free survival (EFS), Neal Shore,

oncodaily.com

1 3 14

Jim Catto @jimcatto.bsky.social · Jan 11

Wow. Great news ... first of a few?

2

Reposted by Jim Catto

Sabine D. Brookman-May, MD, FEBU🚴‍♀️🚴‍♀️🚴‍♀️🏔️⛷️⛰️ @brookmans76.bsky.social · Jan 11

#CREST trial with positive results for #PD-1 in HR #NMIBC!
✅The study evaluated #sasanlimab (PD-1i)+BCG vs standard #BCG (induction + maintenance) in BCG-naïve, HR NMIBC.
✅The study met its primary endpoint with significant improvement of EFS
pfizer.com/news/press-rel…
@oncodaily.bsky.social

https://pfizer.com/news/press-rel…

1 3 6

Jim Catto @jimcatto.bsky.social · Jan 10

7. And when diagnosed, black men and those from deprived areas are marginally less likely to receive radical treatment for locally advanced prostate cancer

Jim Catto @jimcatto.bsky.social · Jan 10

6. But inequalities persist. Most diagnoses in men from affluent areas (blue) and black men have fewer diagnosis despite much higher risk of having #prostatecancer

1

Jim Catto @jimcatto.bsky.social · Jan 10

5. Similar for large bowel toxicity after radiotherapy

1

Jim Catto @jimcatto.bsky.social · Jan 10

4. Good to see rates of Major Urinary events (i.e. mostly a seciond intervention for (in)continence) are low

1

Jim Catto @jimcatto.bsky.social · Jan 10

3. Good to see 92% of low risk disease being managed with Surveillance

1

Jim Catto @jimcatto.bsky.social · Jan 10

2. Good to see diagnosis rate rising ... still catch up for #COVID-19

1

Reposted by Jim Catto

National Prostate Cancer Audit @npca-natcan.bsky.social · Jan 9

Key findings include an increase in men newly diagnosed with prostate cancer: in 2023 in England, a 9% increase when compared to 2022 and a 25% increase compared to 2019. In 2022 in Wales, a 26% increase compared to 2021.

1 2 3

Jim Catto @jimcatto.bsky.social · Jan 10

1. The NPCA reports are always a great snap shot of ProstateCancer in England and Wales. Worth checking out for nation wide disease patterns. www.npca.org.uk ..

National Prostate Cancer Audit

www.npca.org.uk

1

Jim Catto @jimcatto.bsky.social · Jan 10

Geographic patterns of #prostatecancer reflect awareness, mens health and PSA testing. Big differences exist in the UK and other countries @prostatecanceruk.bsky.social

prostatecanceruk.org/about-us/new...

Huge North-South divide in prostate cancer diagnoses

We want to stop prostate cancer being a killer. We fund groundbreaking research, drive improvements in treatment, and fight injustice in care.

prostatecanceruk.org

3 3

Jim Catto @jimcatto.bsky.social · Jan 10

Credit the authors ... its hard to find defendants of TRUS-Bx in an era of TREXIT. RCTs mostly show equivalence but fewer infections - see www.bmj.com/content/387/... There is loss of equipoise amongst urologists. Patient views under-represented.

www.eu-focus.europeanurology.com/article/S240...

DEFINE_ME

www.eu-focus.europeanurology.com

1 1